Hamilton Thorne (TSE:HTL) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Hamilton Thorne Ltd. has reported a robust first quarter for 2024 with a 16% increase in sales to $19.4 million and a 24% rise in Adjusted EBITDA to $3.5 million, showcasing strong financial performance and adherence to their annual guidance. The company observed a significant improvement in gross profit margin to 52.4% and confirmed their full-year sales forecast, indicating a 10-15% organic growth. These results reflect a solid demand for Hamilton Thorne’s products in IVF/ART clinics and laboratories worldwide.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.
